Preventing Gastrointestinal Disturbance in Patients After Longitudinal Laparotomy.

NCT05923086 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2024-10-03

No results posted yet for this study

Summary

This is a multi-center, randomized, double blind, placebo-controlled, phase 2 pilot efficacy study.

Conditions

  • Ileus Postoperative

Interventions

DRUG

ORE001

Administration before major meal

DRUG

Placebo

Administration before major meal

Sponsors & Collaborators

  • QPS Holdings LLC

    collaborator INDUSTRY
  • Orexa BV

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-11
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05923086 on ClinicalTrials.gov